Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IMARA Inc. | Director, 10%+ Owner | Common Stock | 4.2M | $63.6M | $15.14 | Jun 2, 2022 | By OrbiMed Private Investments VII, LP |
Ikena Oncology, Inc. | Director | Common Stock | 91K | $489K | $5.37 | Aug 4, 2023 | Indirect |
Acutus Medical, Inc. | Director | FORM 4 | 20.8K | $3.94K | $0.19 | Jun 15, 2023 | Direct |
Ikena Oncology, Inc. | Director | Non-Voting Common Stock | 5.58M | Aug 4, 2023 | Indirect | ||
Ikena Oncology, Inc. | Director | Series A Preferred Stock | 353K | Aug 4, 2023 | Indirect | ||
Repare Therapeutics Inc. | Director | Stock Option (right to buy) | 27.2K | Jun 17, 2024 | Direct | ||
Prelude Therapeutics Inc | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 23.5K | Jun 14, 2024 | Direct | ||
Third Harmonic Bio, Inc. | Director | Director Stock Option (right to buy) | 20K | Jun 6, 2024 | Direct | ||
Ikena Oncology, Inc. | Director | Stock Option (Right to Buy) | 17.5K | Jun 7, 2024 | Direct | ||
IMARA Inc. | Director, 10%+ Owner | Stock Options (Right to Buy) | 8.5K | Jun 2, 2022 | Direct | ||
Tricida, Inc. | Director, 10%+ Owner | Common Stock | 0 | Nov 25, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPTX | Repare Therapeutics Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
PRLD | Prelude Therapeutics Inc | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director, 10%+ Owner |
IKNA | Ikena Oncology, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
THRD | Third Harmonic Bio, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
IKNA | Ikena Oncology, Inc. | Aug 4, 2023 | 2 | $0 | 4/A | Sep 21, 2023 | Director |
PRLD | Prelude Therapeutics Inc | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director, 10%+ Owner |
AFIB | Acutus Medical, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
IKNA | Ikena Oncology, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
RPTX | Repare Therapeutics Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
THRD | Third Harmonic Bio, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director, 10%+ Owner |
PRLD | Prelude Therapeutics Inc | May 22, 2023 | 1 | $5M | 4 | May 24, 2023 | Director, 10%+ Owner |
THRD | Third Harmonic Bio, Inc. | Mar 6, 2023 | 2 | $0 | 4 | Mar 8, 2023 | Director, 10%+ Owner |
TCDA | Tricida, Inc. | Nov 22, 2022 | 3 | -$2.21M | 4 | Nov 25, 2022 | Director, 10%+ Owner |
THRD | Third Harmonic Bio, Inc. | Oct 26, 2022 | 1 | $0 | 4 | Oct 27, 2022 | Director, 10%+ Owner |
THRD | Third Harmonic Bio, Inc. | Sep 19, 2022 | 5 | $5.1M | 4 | Sep 21, 2022 | Director, 10%+ Owner |
THRD | Third Harmonic Bio, Inc. | Sep 14, 2022 | 0 | $0 | 3 | Sep 14, 2022 | Director, 10%+ Owner |
IKNA | Ikena Oncology, Inc. | Jun 22, 2022 | 4 | -$1.13M | 4 | Jun 24, 2022 | Director |
PRLD | Prelude Therapeutics Inc | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director, 10%+ Owner |
AFIB | Acutus Medical, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director, 10%+ Owner |
TCDA | Tricida, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director, 10%+ Owner |
IKNA | Ikena Oncology, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
ELVN | IMARA Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director, 10%+ Owner |
RPTX | Repare Therapeutics Inc. | May 13, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
IKNA | Ikena Oncology, Inc. | Dec 21, 2021 | 1 | $0 | 4 | Dec 23, 2021 | Director |
TCDA | Tricida, Inc. | Nov 15, 2021 | 2 | $4M | 4 | Nov 17, 2021 | Director, 10%+ Owner |
RPTX | Repare Therapeutics Inc. | Sep 3, 2021 | 4 | -$275K | 4 | Sep 8, 2021 | Director |
RPTX | Repare Therapeutics Inc. | Aug 31, 2021 | 6 | -$1.29M | 4 | Sep 2, 2021 | Director |
RPTX | Repare Therapeutics Inc. | Aug 26, 2021 | 6 | -$616K | 4 | Aug 30, 2021 | Director |
RPTX | Repare Therapeutics Inc. | Aug 23, 2021 | 6 | -$622K | 4 | Aug 25, 2021 | Director |
RPTX | Repare Therapeutics Inc. | Aug 17, 2021 | 4 | -$693K | 4 | Aug 25, 2021 | Director |
RPTX | Repare Therapeutics Inc. | Aug 17, 2021 | 4 | -$693K | 4 | Aug 19, 2021 | Director |
AFIB | Acutus Medical, Inc. | Jul 19, 2021 | 2 | $15M | 4 | Jul 21, 2021 | Director, 10%+ Owner |
ELVN | IMARA Inc. | Jul 16, 2021 | 1 | $10M | 4/A | Jul 23, 2021 | Director, 10%+ Owner |
ELVN | IMARA Inc. | Jun 29, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director, 10%+ Owner |
PRLD | Prelude Therapeutics Inc | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director, 10%+ Owner |
AFIB | Acutus Medical, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 22, 2021 | Director, 10%+ Owner |
TCDA | Tricida, Inc. | Jun 10, 2021 | 2 | $0 | 4 | Jun 11, 2021 | Director, 10%+ Owner |
RPTX | Repare Therapeutics Inc. | May 13, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |